Clinical Trial Update: Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating phentermine/topiramate extended-release for binge eating disorder has completed. The study was sponsored by the Lindner Cent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Qsymia (phentermine/topiramate)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder | Phase 2 | Status: COMPLETED